REGENXBIO Ownership | Who Owns REGENXBIO?


OverviewForecastRevenueFinancialsChartTranscripts

REGENXBIO Ownership Summary


REGENXBIO is owned by 95.64% institutional investors, 7.39% insiders. Blackrock is the largest institutional shareholder, holding 18.83% of RGNX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.86% of its assets in REGENXBIO shares.

RGNX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockREGENXBIO95.64%7.39%-3.03%
SectorHealthcare Stocks 46.98%7.90%45.12%
IndustryBiotech Stocks 44.85%7.67%47.48%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock8.61M18.83%$100.73M
Vanguard group5.11M11.18%$59.83M
Redmile group4.57M9.99%$53.47M
Jpmorgan chase3.01M6.59%$35.25M
State street2.87M6.28%$33.62M
Avidity partners management lp1.30M2.84%$15.21M
Morgan stanley1.18M2.58%$13.80M
Dimensional fund advisors lp1.11M2.42%$12.96M
Geode capital management1.04M2.28%$12.22M
Integral health asset management950.00K2.08%$11.12M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sonic gp453.08K10.94%$5.30M
Aquilo capital management906.25K10.22%$10.60M
Redmile group4.57M3.23%$53.47M
Integral health asset management950.00K1.06%$11.12M
Bioimpact capital557.08K1.01%$6.52M
Archpoint investors224.28K0.99%$2.62M
Lion point capital, lp36.25K0.77%$424.13K
Avidity partners management lp1.30M0.65%$15.21M
Ghost tree capital170.00K0.62%$1.99M
Napatree capital49.76K0.47%$582.24K

Top Buyers

HolderShares% AssetsChange
Blackrock8.61M0.00%1.01M
Assenagon asset management816.38K0.02%588.77K
Balyasny asset management806.72K0.02%379.76K
Vanguard group5.11M0.00%236.90K
Integral health asset management950.00K1.06%190.00K

Top Sellers

HolderShares% AssetsChange
Jpmorgan chase3.01M0.00%-710.08K
State street2.87M0.00%-249.40K
Mirae asset global investments1.47K0.00%-168.75K
Adage capital partners gp---165.07K
Morgan stanley1.18M0.00%-159.99K

New Positions

HolderShares% AssetsChangeValue
Norges bank147.55K0.00%147.55K$1.73M
Mirae asset global etfs109.72K0.00%109.72K$1.28M
Allianz asset management gmbh92.60K0.00%92.60K$1.08M
Ubs oconnor70.20K0.05%70.20K$821.33K
Walleye capital55.58K0.00%55.58K$650.24K

Sold Out

HolderChange
Rothschild investment-5.00
Innealta capital-8.00
Nelson, van denburg & campbell wealth management group-8.00
Private wealth management group-27.00
Riggs asset managment-34.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024181-5.73%43,737,0103.28%951.02%100-1.96%44-15.38%
Mar 31, 202419210.34%42,349,93811.14%961.29%10225.93%52-11.86%
Dec 31, 20231746.10%38,106,0922.54%861.19%816.58%5915.69%
Sep 30, 2023164-5.75%37,163,0120.15%851.17%76-2.56%51-12.07%
Jun 30, 2023174-1.69%37,108,3470.15%851.17%78-58-12.12%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF2.90M5.86%3.04K
Vanguard Total Stock Mkt Idx Inv1.40M2.83%-
iShares Russell 2000 ETF1.18M2.39%-2.66K
JPMorgan Small Cap Growth A1.16M2.35%-
SPDR® S&P Biotech ETF845.24K1.71%9.34K
Vanguard Institutional Extnd Mkt Idx Tr735.47K1.49%-12.35K
Vanguard Small Cap Index557.49K1.13%-562.53K
Fidelity Small Cap Index469.69K0.95%-11.94K
iShares Russell 2000 Value ETF434.01K0.88%-
SPDR® Portfolio S&P 600™ Sm Cap ETF403.70K0.82%3.04K

Recent Insider Transactions


DateNameRoleActivityValue
Oct 01, 2024KARABELAS ARGERIS N-Sell$101.05K
Sep 03, 2024KARABELAS ARGERIS N-Sell$106.95K
Sep 03, 2024KARABELAS ARGERIS N-Sell$8.64K
Aug 01, 2024KARABELAS ARGERIS N-Sell$129.12K
Aug 01, 2024KARABELAS ARGERIS N-Sell$5.83K

Insider Transactions Trends


DateBuySell
2024 Q4-1
2024 Q3-13
2024 Q2-2
2024 Q1-6
2023 Q4-1

RGNX Ownership FAQ


Who Owns REGENXBIO?

REGENXBIO shareholders are primarily institutional investors at 95.64%, followed by 7.39% insiders and -3.03% retail investors. The average institutional ownership in REGENXBIO's industry, Biotech Stocks , is 44.85%, which REGENXBIO exceeds.

Who owns the most shares of REGENXBIO?

REGENXBIO’s largest shareholders are Blackrock (8.61M shares, 18.83%), Vanguard group (5.11M shares, 11.18%), and Redmile group (4.57M shares, 9.99%). Together, they hold 40.00% of REGENXBIO’s total shares outstanding.

Does Blackrock own REGENXBIO?

Yes, BlackRock owns 18.83% of REGENXBIO, totaling 8.61M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 100.73M$. In the last quarter, BlackRock increased its holdings by 1.01M shares, a 13.29% change.

Who is REGENXBIO’s biggest shareholder by percentage of total assets invested?

Sonic gp is REGENXBIO’s biggest shareholder by percentage of total assets invested, with 10.94% of its assets in 453.08K REGENXBIO shares, valued at 5.3M$.

Who is the top mutual fund holder of REGENXBIO shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of REGENXBIO shares, with 5.86% of its total shares outstanding invested in 2.9M REGENXBIO shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools